Selectis Health, Inc. Reports Net Loss of $2.4 Million for 2022

Selectis Health, Inc.,(GBCS) a leading healthcare servic es provider, released its consolidated financial statements for the twelve months ended December 31, 2022. The company reported a net loss of $2.4 million for the year, while its revenue reached $40.5 million. Despite the challenging operating environment, Selectis Health achieved steady revenue growth, driven by strong performances in rental revenue, healthcare revenue, healthcare grant revenue, and management fee revenue.

Revenue Growth and Segment Breakdown:
Selectis Health experienced robust revenue growth in 2022, totaling $40.5 million, compared to $29.3 million in the previous year. The revenue growth was primarily attributed to the following segments:

Rental Revenue: Selectis Health generated $591,808 in rental revenue for the year, contributing to its overall revenue growth.

Healthcare Revenue: The healthcare services segment performed exceptionally well, recording $36.7 million in revenue for 2022, compared to $26.9 million in 2021. This significant increase can be attributed to the company's efforts to expand its service offerings and meet the rising demand for quality healthcare services.